Related Experiment Video
Updated: May 30, 2026
10:51
Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
p38 and p42/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization
Junaid A Khan1, Larbi Amazit, Catherine Bellance
1Institut National de la Santé et de la Recherche Médicale Unité 693, Université Paris-Sud, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, France.
Molecular Endocrinology (Baltimore, Md.)
|August 6, 2011
Summary
The study reveals that mitogen-activated protein kinase (MAPK) signaling differentially controls progesterone receptor (PR) isoforms (PRA and PRB) stability. This differential regulation impacts the PRA/PRB ratio, potentially contributing to breast cancer progression.
Area of Science:
- Endocrinology
- Molecular Biology
- Cancer Research
Background:
- Progesterone receptor (PR) isoforms, PRA and PRB, are crucial in breast cancer, with imbalanced ratios linked to disease progression.
- Antiprogrestins are potential treatments for hormone-dependent cancers, but their mechanisms involving PR isoform stability require elucidation.
Purpose of the Study:
- To investigate the mechanisms controlling progesterone receptor (PR) isoform degradation and stability under agonist and antagonist ligand conditions.
- To understand the role of MAPK signaling pathways in regulating PR isoform stability and the PRA/PRB ratio.
Main Methods:
- Utilized cancer cell lines stably expressing PRA and/or PRB.
- Investigated PR isoform turnover, degradation, and phosphorylation in response to ligands and MAPK pathway modulators.
- Analyzed the impact of MAPK signaling on PR target gene expression.
Main Results:
- The antiprogestin RU486 inhibited agonist-induced PR isoform turnover via MAPK-dependent phosphorylation.
- p42/44 MAPK activity protected RU486-bound PRB from proteasomal degradation, while p38 MAPK activation stabilized PRA.
- MAPK signaling differentially controlled PR isoform stability, influencing the PRA/PRB ratio independently of PR serine-294 phosphorylation.
Conclusions:
- MAPK-mediated signaling differentially regulates the PRA/PRB expression ratio at the posttranslational level through ligand-sensitive mechanisms.
- Disruptions in MAPK signaling may lead to imbalanced PRA/PRB ratios, contributing to breast cancer pathogenesis.
- Understanding these MAPK-dependent mechanisms offers insights into targeted therapies for hormone-dependent cancers.
Related Concept Videos
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...